SMYD2A anticorps (AA 1-270)
-
- Antigène Voir toutes SMYD2A Anticorps
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
-
Épitope
- AA 1-270
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SMYD2A est non-conjugé
-
Application
- Western Blotting (WB), Immunofluorescence (IF)
- Séquence
- MRAEGLGGLE RFCSPGKGRG LRALQPFQVG DLLFSCPAYA YVLTVNERGN HCEYCFTRKE GLSKCGRCKQ AFYCNVECQK EDWPMHKLEC SPMVVFGENW NPSETVRLTA RILAKQKIHP ERTPSEKLLA VKEFESHLDK LDNEKKDLIQ SDIAALHHFY SKHLGFPDND SLVVLFAQVN CNGFTIEDEE LSHLGSAIFP DVALMNHSCC PNVIVTYKGT LAEVRAVQEI KPGEEVFTSY IDLLYPTEDR NDRLRDSYFF TCECQECTTK
- Réactivité croisée
- Humain, Souris
- Attributs du produit
- Polyclonal Antibodies
- Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-270 of human SMYD2 (NP_064582.2).
- Isotype
- IgG
- Top Product
- Discover our top product SMYD2A Anticorps primaire
-
-
- Indications d'application
- WB,1:500 - 1:2000,IF,1:10 - 1:100
- Commentaires
-
HIGH QUALITY
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling." dans: The Journal of biological chemistry, Vol. 292, Issue 30, pp. 12702-12712, (2017) (PubMed).
: "
-
The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling." dans: The Journal of biological chemistry, Vol. 292, Issue 30, pp. 12702-12712, (2017) (PubMed).
-
- Antigène
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
- Autre désignation
- SMYD2 (SMYD2A Produits)
- Synonymes
- anticorps HSKM-B, anticorps KMT3C, anticorps ZMYND14, anticorps 1110020E07Rik, anticorps 4930402C15, anticorps Zmynd14, anticorps smyd2-a, anticorps im:7146196, anticorps smyd2, anticorps wu:fc02f02, anticorps zgc:110553, anticorps si:dkey-121j17.3, anticorps zgc:136609, anticorps SET and MYND domain containing 2, anticorps SET and MYND domain containing 2 S homeolog, anticorps SET and MYND domain containing 2a, anticorps SET and MYND domain containing 2b, anticorps SMYD2, anticorps Smyd2, anticorps smyd2.S, anticorps smyd2a, anticorps smyd2b
- Sujet
- SET domain-containing proteins, such as SMYD2, catalyze lysine methylation (Brown et al., 2006 [PubMed 16805913]).[supplied by OMIM, Nov 2008],SMYD2,HSKM-B,KMT3C,ZMYND14,Epigenetics & Nuclear Signaling,Chromatin Modifying Enzymes,Methylation,SMYD2
- Poids moléculaire
- 30 kDa/49 kDa
- ID gène
- 56950
- UniProt
- Q9NRG4
-